Cardiomyopathies et péricardite
JESFC 2025

Amylose - Cardiomyopathies

Publié le jeudi 16 janvier 2025

Modérateur(s) :

Diane Bodez , Julie Proukhnitzky

Orateur(s) :

Yassine Ettagmouti , Alexandre Unger , Amira Zaroui , Ilyes Bouaguel , Emmanuelle Berthelot , Mariarosaria Magaldi , Atul Pathak , Théo Simon , Michel Slama , Nora Ali Tatar

Dans la session

Amira Zaroui Wild-type transthyretin cardiac amyloidosis: sex differences in prevalence, cardiac and extracardiac phenotypes, and prognosis
Ilyes Bouaguel Prognostic Value of Body Mass Index and Waist Circumference in Patients With Chronic Heart Failure: Algerian experience
Emmanuelle Berthelot Pulmonary hypertension in heart failure with preserved ejection fraction: impact on mortality and hospitalization risk in PHHF registry
Mariarosaria Magaldi Predicting One-Year Mortality after Discharge Using Acute Heart Failure Score (AHFS)
Atul Pathak Newcard telemonitoring system improves survival in comparison with other French telemonitoring systems in chronic heart failure as assessed by data...
Amira Zaroui What about markers inflammation on cardiac amyloidosis?
Théo Simon Unique nature of sickle sell diastolic cardiomyopathy: a tailored echocardiographic definition to refine prognostic stratification in young adults
Michel Slama Cardiac amyloidosis: which are the TTR variants associated with early occurence of ATTRv-CM?
Nora Ali Tatar Mulmodality imaging in arrhythmogenic right ventricular dysplasia: from real life to guidelines: about 18 years observation
Amira Zaroui Impact of Accelerating Resting Heart Rate in Transthyretin Cardiac Amyloidosis on Functional and Hemodynamic Echocardiographic Parameters
Yassine Ettagmouti Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction in Morocco
Alexandre Unger Improving prognostic accuracy in ischemic cardiomyopathy: the ?CMR-LGE score?

Partager l'article :